Bifidobacteria and its rice fermented products on diet induced obese mice: Analysis of physical status, serum profile and gene expressions

Beneficial Microbes

Volumn 9, Issue 3, 2018, Pages 441-452

  Ray, M ^a   Hor, P K ^a   Ojha, D ^b   Soren, J P ^a   Singh, S N ^c   Mondal, K C ^a  

^a VIDYASAGAR UNIVERSITY   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Anti obesity; Bifidobacterium spp.; Lipid profile; Rice beverage

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROBIOTIC AGENT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCOUPLING PROTEIN 3; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL;

ACC GENE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGPTL4 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL GROWTH; BIFIDOBACTERIUM; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CPT1 GENE; DOWN REGULATION; FATTY ACID SYNTHESIS; FERMENTED PRODUCT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUT4 GENE; INTESTINE FLORA; LACTOBACILLUS; LIPID BLOOD LEVEL; LIVER STRUCTURE; MALE; MOUSE; NONHUMAN; OBESITY; PPAR ALPHA GENE; PPAR DELTA GENE; PPAR GAMMA GENE; RICE; SREBP 1C GENE; TNF ALPHA GENE; TRIACYLGLYCEROL BLOOD LEVEL; UCP3 GENE; UPREGULATION; ANALYSIS; ANIMAL; BLOOD; BODY WEIGHT; CHEMISTRY; CYTOCHEMISTRY; DIET THERAPY; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; LIVER; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; ORYZA; PATHOLOGY; PROCEDURES; SERUM; TREATMENT OUTCOME;

ANIMALS; BIFIDOBACTERIUM; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIET THERAPY; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; LIVER; MALE; MICE, OBESE; OBESITY; ORYZA; PROBIOTICS; SERUM; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 85045287024     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2017.0056     Document Type: Article

References (42)

1. Alard, J., Lehrter, V., Rhimi, M., Manqin, I., Peucelle, V., Abraham, A.L., Mariadassou, M., Maquin, E., Waliqora-Dupriet, A.J., Pot, B., Wolowczuk, I. and Granqrtte, C., 2016. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environmental Microbiology 18: 1484-1497.
2. Bindels, L.B., Dewulf, E.M. and Delzenne, N.M., 2013. GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends in Pharmacological Sciences 34: 226-232.
3. Bray, G.A. and Tartaglia, L.A., 2000. Medicinal strategies in the treatment of obesity. Nature 404: 672-677.
4. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Buecelin, R.G., Tuohy, K.M., Gibson, G.R. and Deizenne, N.M., 2007. Selective increases of bifidobacteria in gut microflora improves high-fat diet induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia 50: 374-383.
5. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D.M., Muccioli, G.G. and Delzenne, N.M., 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
6. Chen, J.J., Wang, R., Li, X.F. and Wang, R.L., 2011. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Experimental Biology and Medicine 236: 823-831.
7. Delzenne, N.M. and Cani, P.D., 2011. Interaction between obesity and the gut microbiota: relevance in nutrition. Annual Review of Nutrition 31: 15-31.
8. Du Toit, M., Franz, C.M., Dicks, L.M., Schillinger, U., Haberer, P., Warlies, B., Arhens, F. and Holzapfel, W.H., 1998. Characterization and selection of probiotic lactobacilli for a preliminary mini pig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. International Journal of Food Microbiology 40: 93-104.
9. Esposito, E., Iacono, A., Bianco, G., Autore, G., Cuzzocrea, S., Vajro, P., Canani, R.B., Caliqnano, A., Raso, G.M. and Meli, R., 2009. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. Journal of Nutrition 139: 905-911.
10. Gueimonde, M. and Sánchez, B., 2012. Enhancing probiotic stability in industrial processes. Microbial Ecology in Health and Disease 23: 18562.
11. Hamad, E.M., Sato, M., Uzu, K., Yoshida, T., Higashi, S., Kawakami, H., Kadooka, Y., Matsuyama, H., Abd El-Gawad, I.A. and Imaizumi, K., 2009. Milk fermented by Lactobacillus gasseri SBT 2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. British Journal of Nutrition 101: 716-724.
12. Kalliomaki, M., Collado, M.C., Salminen, S. and Isolauri, E., 2008. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 87: 534-538.
13. Kang, J.-H., Yun, S.-I., Park, M.-H., Park, J.-H., Jeong, S.-Y. and Park, H.-O., 2013. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PloS One 8: e54617.
14. Kimura, I., Inoue, D., Hirano, K. and Tsujimoto, G., 2014. The SCFA receptor GPR43 and energy metabolism. Frontiers in Endocrinology 5: 85.
15. Kobyliak, N., Conte, C., Cammarota, G., Haley, A.P., Styriak, I., Gaspar, L., Fusek, J., Rodrigo, L. and Kruzliak, P., 2016. Probiotics in prevention and treatment of obesity: a critical view. Nutrition and Metabolism 13: 14-27.
16. Kondo, S., Xiao, J.Z., Satoh, T., Satoh, T., Odamaki, T., Takahashi, S., Suqahara, H., Yaeshima, T., Iwatsuki, K., Kamei, A. and Abe, K., 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet induced obesity. Bioscience, Biotechnology, and Biochemistry 74: 1656-1666.
17. Korner, J. and Aronne, L.J., 2004. Pharmacological approaches to weight reduction: therapeutic targets. Journal of Clinical Endocrinology and Metabolism 89: 2616-2621.
18. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannay, V., Decobecq, M.E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., Paementier, M. and Detheux, M., 2003. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. Journal of Biological Chemistry 278: 25481-25489.
19. Lim, H.J., Kim, S.Y. and Lee, W.K., 2004. Isolation of cholesterol-lowering lactic acid bacteria from human intestine for probiotic use. Journal of Veterinary Sciences 5: 391-395.
20. Million, M., Maraninchi, M., Henry, M., Armouqom, F., Richet, H., Carrieri, P., Valero, R., Raccah, D., Vialettes, B. and Raoult, D., 2012. Obesity associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of Obesity 36: 817-825.
21. Miyamoto, J., Hasegawa, S., Kasubuchi, M., Ichimura, A., Nakajima, A. and Kimura, I., 2016. Nutritional signalling via free fatty acid receptors. International Journal of Molecular Sciences 17: 450-462.
22. Mohan Reddy, N., Kalyana, K.C. and Jamil, K., 2012. New World Syndrome (obesity) in South India. Scientific Reports 1: 567.
23. Mondal, K.C., Ghosh, K., Mitra, B., Parua, S. and Das Mohapatra, P.K., 2016. Rice-based fermented foods and beverages: functional and nutraceutical properties. In: Ramesh, C., Ray, R.C. and Montet, D. (eds.) Fermented foods, part II: technological intervention. CRC Press, New York, NY, USA, pp. 150-176.
24. National Institute of Health (NIH), 1998. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National Hearth Lung and Blood Institute, Bethesda, MD, USA. Available at: http://tinyurl.com/y8eo47lp.
25. Nishida, C. and Mucavele, P., 2005. Monitoring the rapidly emerging public health problem of overweight and obesity: the WHO Global Database on Body Mass Index. SCN News 129: 5-12.
26. Nova, E., De Heredia, F.P., Gómez-Martínez, S. and Marcos, A., 2016. The role of probiotics on the microbiota: effect on obesity. Nutrition in Clinical Practice 31: 387-400.
27. Ooi, L.G. and Liong, M.T., 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. International Journal of Molecular Sciences 11: 2499-2522.
28. Patel, A.K., Singhania, R.R., Pandey, A. and Chincholkar, S.B., 2010. Probiotic bile salt hydrolase: current developments and perspectives. Applied Biochemistry and Biotechnology 162: 166-180.
29. Pradeepa, R., Anjana, R.M., Joshi, S.R., Bhansali, A., Deepa, M., Joshi, P.P., Dhandania, V.K., Madhu, S.V., Rao, P.V., Geetha, L., Subashini, R., Unnikrishnan, R., Shukla, D.K., Kaur, T., Mohan, V., Das, A.K., 2015. Prevalence of generalized and abdominal obesity in urban and rural India - the ICMR-INDIAB study (Phase-I) [ICMR-INDIAB-3]. Indian Journal of Medical Research 142: 139-150.
30. Ray, M., Ghosh, K., Har, P.K., Singh, S.N. and Mondal, K.C., 2017. Fortification of rice gruel into functional beverage and establishment as a carrier of newly isolated Bifidobacterium sp. MKK4. Research Journal of Microbiology 12: 102-117.
31. Ray, M., Ghosh, K., Har, P.K., Singh, S.N. and Mondal, K.C., 2017. Screening of health beneficial microbes with potential probiotic characteristics from the traditional rice based alcoholic beverage, haria. Acta Biologica Szegediensis 61: 51-58.
32. Seo, J.B., Choe, S.S., Jeong, H.W., Park, S.W., Shin, H.J., Choi, S.M., Park, J.Y., Choi, E.W., Kim, J.B., Seen, D.S., Jeong, J.Y. and Lee, T.G., 2011. Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism. Experimental and Molecular Medicine 43: 205-215.
33. Shori, A.B., 2016. Influence of food matrix on the viability of probiotic bacteria: a review based on dairy and non-dairy beverages. Food Bioscience 13: 1-8.
34. Strychar, I., 2006. Diet in the management of weight loss. Canadian Medical Association Journal 3: 56-63.
35. Tan, S., Gao, B., Tao, Y., Guo, J. and Su, Z., 2014. Antiobese effects of capsaicin-chitosan microsphere (CCMS) in obese rats induced by high fat diet. Journal of Agricultural and Food Chemistry 62: 1866-1874.
36. Tarantino, G., 2014. Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation. Journal of Clinical Endocrinology and Metabolism 99: 2343-2346.
37. World Health Organization (WHO), 2000. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. World Health Organ Tech Report Series 894: i-xii, 1-253.
38. Wronska, A. and Kmiec, Z., 2012. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiologica 205: 194-208.
39. Xiao, J.Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., Kokubo, S. and Hosono, A., 2003. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Journal of Dairy Science 86: 2452-2461.
40. Yadav, H., Lee, J.H., Lloyd, J., Walter, P. and Rane, S.G., 2013. Beneficial metabolic effects of a probiotic via butyrate induced GLP-1 secretion. Journal of Biological Chemistry 288: 25088-25097.
41. Yin, Y.N., Yu, Q.F., Fu, N., Liu, X.W. and Lu, F.G., 2010. Effects of four bifidobacteria on obesity in high-fat diet induced rats. World Journal of Gastroenterology 16: 3394-3401.
42. Zeng, H., Liu, J., Jackson, M.I., Zhao, F.Q., Yan, L. and Combs Jr., G.F., 2013. Fatty liver accompanies an increase in Lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. Journal of Nutrition 143: 627-631.